Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06686186

Hainan Community Cognition Cohort

A Prospective Cohort of Hainan Community Elderly Population with Cognitive Impairment

Status
Recruiting
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
Hainan Medical College · Academic / Other
Sex
All
Age
60 Years – 120 Years
Healthy volunteers
Accepted

Summary

This is a community-based prospective cohort study in Hainan Province, China. The study was initialized in 2023 and included older residents for longitudinal follow-up. The research aims to identify risk factors as well as health and social outcomes that are associated with cognitive impairment in elderly populations, and independently develop AI-assisted software and applications for cognitive enhancement and physical rehabilitation training.

Detailed description

This is a community-based prospective cohort study in Hainan Province, China. Subjects are individuals aged 60 years and above who have lived in the communities for more than six months and have signed informed consent. The research have been initialed in 2023 and aims to identify the risk factors associated with cognitive impairment, to develop software for cognitive enhancement and physical rehabilitation training. The study includes three steps: first, to conduct cognitive function screening in 16 communities in four districts (Xiuying, Meilan, Longhua, and Qiongshan) of Haikou City and establish a database for the elderly in tropical regions; second, to identify risk factors associated with cognitive impairment in the elderly population; finally, to independently develop a software for cognitive function enhancement and physical rehabilitation training.

Conditions

Interventions

TypeNameDescription
OTHERNo Intervention: Observational CohortThere were no interventions in our cohort. The subjects of our cohort were and will be followed up at the regular intervals.

Timeline

Start date
2022-12-16
Primary completion
2053-12-31
Completion
2053-12-31
First posted
2024-11-13
Last updated
2024-11-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06686186. Inclusion in this directory is not an endorsement.